TY - JOUR
T1 - Longer Sleep Duration and Endothelial Cell Health among a Multiethnic Sample of Adolescents
AU - Alcántara, Carmela
AU - Giorgio Cosenzo, Luciana
AU - Leigh, Adam K.K.
AU - Shimbo, Daichi
AU - Miller, Gregory E.
N1 - Funding Information:
Source of Funding and Conflicts of Interest: C.A. is supported by K23 HL125748, G.E.M. is supported by R01 HL122328, and D.S. is supported by K24-HL125704 from the National Heart, Lung, and Blood Institute of the National Institutes of Health. No conflicts of interest to report.
PY - 2019/11/1
Y1 - 2019/11/1
N2 - Objective Adverse endothelial cell health, an early pathogenic process underlying atherosclerosis and cardiovascular disease, is evident in childhood and adolescence. Sleep duration, a modifiable cardiovascular health behavior, may be an important cardiovascular disease prevention target that may affect endothelial cell health. We examined the associations of longer sleep duration with endothelial cell injury among youth. Methods In a multiethnic sample of 235 children (63.0% female, mean age = 13.9 years), we conducted multivariable linear regressions to test the cross-sectional association of sleep duration and circulating levels of endothelial cell-derived microparticles (EMPs), phenotypic for endothelial cell activation and apoptosis (CD62E+ EMPs, CD31+/CD42b-EMPs, and CD31+/Annexin V+ EMPs). Sleep duration and EMPs were both treated as continuous variables. Models were adjusted for age, sex, race, pubertal status, household economic resources, and waist circumference. Results Overall, 69.2% had short sleep duration (<8 hours of sleep per night). Longer sleep duration was significantly associated with lower levels of CD62E+ EMPs and CD31+/CD42b-EMPs. A 60-minute increase in sleep duration was associated with an 8.40 (95% confidence interval =-205.20 to-1.80, p =.046) decrease in CD62E+ EMPs and a 9.00 (95% confidence interval =-153.60 to-9.60, p =.027) decrease in CD31+/CD42b-EMPs. Sleep duration was not associated with CD31+/Annexin V+ EMPs. Conclusions Our results support the hypothesis that sleeping longer has beneficial effects on endothelial cell health during childhood. Primordial prevention efforts might incorporate sleep extension to offset cardiovascular risk in youth.
AB - Objective Adverse endothelial cell health, an early pathogenic process underlying atherosclerosis and cardiovascular disease, is evident in childhood and adolescence. Sleep duration, a modifiable cardiovascular health behavior, may be an important cardiovascular disease prevention target that may affect endothelial cell health. We examined the associations of longer sleep duration with endothelial cell injury among youth. Methods In a multiethnic sample of 235 children (63.0% female, mean age = 13.9 years), we conducted multivariable linear regressions to test the cross-sectional association of sleep duration and circulating levels of endothelial cell-derived microparticles (EMPs), phenotypic for endothelial cell activation and apoptosis (CD62E+ EMPs, CD31+/CD42b-EMPs, and CD31+/Annexin V+ EMPs). Sleep duration and EMPs were both treated as continuous variables. Models were adjusted for age, sex, race, pubertal status, household economic resources, and waist circumference. Results Overall, 69.2% had short sleep duration (<8 hours of sleep per night). Longer sleep duration was significantly associated with lower levels of CD62E+ EMPs and CD31+/CD42b-EMPs. A 60-minute increase in sleep duration was associated with an 8.40 (95% confidence interval =-205.20 to-1.80, p =.046) decrease in CD62E+ EMPs and a 9.00 (95% confidence interval =-153.60 to-9.60, p =.027) decrease in CD31+/CD42b-EMPs. Sleep duration was not associated with CD31+/Annexin V+ EMPs. Conclusions Our results support the hypothesis that sleeping longer has beneficial effects on endothelial cell health during childhood. Primordial prevention efforts might incorporate sleep extension to offset cardiovascular risk in youth.
KW - Vascular endothelium
KW - cardiovascular disease
KW - sleep
KW - youth
UR - http://www.scopus.com/inward/record.url?scp=85074551786&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074551786&partnerID=8YFLogxK
U2 - 10.1097/PSY.0000000000000745
DO - 10.1097/PSY.0000000000000745
M3 - Article
C2 - 31592937
AN - SCOPUS:85074551786
VL - 81
SP - 778
EP - 781
JO - Psychosomatic Medicine
JF - Psychosomatic Medicine
SN - 0033-3174
IS - 9
ER -